Business Wire

FPT Software Opens New Office in Denmark, Targeting Nordic Region

16.9.2022 00:15:00 EEST | Business Wire | Press release

Share

FPT Software, Vietnam’s leading IT solutions provider, recently announced the opening of its first office in the Scandinavian region and the 59th office internationally.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220905005353/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

From left to right, FPT Software Europe CEO, Mr. Le Hai; FPT Corporation Chairman, Dr. Truong Gia Binh; Denmark’s State Secretary for Trade and Global Sustainability, H.E. Ms. Lina Gandløse Hansen; Vietnamese Ambassador to Denmark, H.E. Mr. Luong Thanh Nghi; Vido Group Founder, Ms. Nguyen Tuyet Mai; Vido Group Denmark CEO, Mr. Jesper G. Jensen. (Photo by Vietnam News Agency)

Within the framework of the Vietnam - Denmark Business Forum, FPT Software and Vido Group, Vietnam’s leading travel services provider, had a joint ribbon-cutting ceremony, marking both companies’ first footprint in Denmark. The event was hosted by the Embassy of Vietnam in Denmark, FPT Software and Vido Group, and was attended by Denmark’s State Secretary for Trade and Global Sustainability, H.E. Ms. Lina Gandløse Hansen, Vietnamese Ambassador to Denmark, H.E. Mr. Luong Thanh Nghi, and executives from Vietnam and Denmark’s companies.

The new office extends FPT Software’s presence in Europe to seven countries and aims at exploring opportunities for sustainable and innovative business growth. It is located in Kongens Lyngby, a commercial area and home to major companies, including Microsoft, COWI A/S, Bang & Olufsen, among others.

“Denmark is one of Vietnam’s largest foreign investors. As Vietnam’s leading corporation, FPT believes that with this newly opened office, we could contribute to strengthening the relationship between the two countries and act as a bridge between both sides’ businesses," FPT Chairman, Dr. Truong Gia Binh said. “We are committed to accompanying Danish and other Nordic customers with our investments, digital technologies, and talents,” he pledged.

“I am very pleased to see FPT Software, a Vietnamese pioneering company in IT services, open its representative office in Denmark. This is the first time a big Vietnamese enterprise has set foot in the Danish market, one with very high standards. FPT Software's presence in Denmark, one of the world's leading countries in technology and digital transformation, has shown that Vietnamese businesses can fully reach out to the world,” Vietnamese Ambassador to Denmark Luong Thanh Nghi said.

“I believe that the presence of enterprises like FPT in Denmark or Carlsberg and LEGO in Vietnam will contribute to promoting, strengthening, and deepening the comprehensive partnership between Vietnam and Denmark. The Embassy of Vietnam in Denmark is committed to supporting and serving the interests of the people and businesses of the two countries,” Vietnamese Ambassador to Denmark Luong Thanh Nghi added.

The ceremony was followed by two panel discussions on how businesses and governments of Vietnam and Denmark can cooperate to promote digital transformation and green transition, as demonstrated by successful cases and experiences from top enterprises like LEGO, Covestro, and Schaeffler. As the Head of the Private Economic Development Research Board under the Government's Advisory Council on Administrative Procedure Reform, Dr. Truong Gia Binh also shared his insights on these matters.

Scandinavia has been at the forefront of digital transformation. Being the region’s success story, the Danish Government recently launched a new digitalization strategy in May 2022 with the vision to accelerate green transition, increase growth, talents, and exports with digital innovations. This provides foreign investors in such fields as AI, Fintech, Robotics, among others, with opportunities to expand in Scandinavia. With the new office in Denmark, FPT Software can extend its support to organizations in the region to address their demands on digital talent and emerging technologies.

The newly inaugurated office asserts FPT Software’s rapid growth and a strong commitment to expanding its European team. 2022 marks FPT Software’s 10th year of operation in Europe. After a decade, FPT Software Europe currently has 500 employees working across seven countries in the region and serves a clientele of nearly 100 organizations, including RWE, Schaeffler, Airbus, E.ON, and more. The company sets sights on becoming one of the Top 10 Digital Transformation services providers in Europe by 2025.

About FPT Software

FPT Software is a global technology and IT services provider headquartered in Vietnam, with more than USD 632.5 million in revenue and 25,500 employees in 28 countries. As a pioneer in digital transformation, the company delivers world-class services in Smart factory, Digital platforms, RPA, AI, IoT, Cloud, AR/VR, BPO, and more. It has served 1,000+ customers worldwide, a hundred of which are Fortune Global 500 companies in the industries of Automotive, Banking and Finance, Logistics & Transportation, Utilities, and more. For further information, please visit http://www.fpt-software.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media

Mai Duong (Ms.)
FPT Software
PR Manager
Email: MCP.PR@fsoft.com.vn
Website: https://www.fpt-software.com/newsroom/

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye